Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
1-15 of 316
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Understanding the Growing Burden of Early-Onset CRC
On the Frontlines of Colorectal CancerUnderstanding the Growing Burden of Early-Onset CRC
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALLNeighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Integrating Molecular Testing into NSCLC Care
Project Oncology®Integrating Molecular Testing into NSCLC Care
- advertisement
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®A New Era of Hope in Non-Small Cell Lung Cancer Care
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Project Oncology®Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®Smarter Screening for Non-Small Cell Lung Cancer
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstractsImproving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®Cosibelimab Delivers Durable Responses in Advanced CSCC
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
- advertisement
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®Oncogenic Drivers in Never-Smokers with NSCLC
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®Expanding Molecular Testing in Community NSCLC Care
